ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a blank-check company sponsored by ARYA Sciences Management, an affiliate of Perceptive Advisors, a healthcare-focused investment manager with a long record in the life sciences space. The SPAC completed its initial public offering in 2021 and focuses its acquisition search on life sciences and biopharmaceutical targets. ARYD is the fourth vehicle in ARYA Sciences' series of healthcare-oriented acquisition companies. The company filed its annual 10-K with the SEC on March 29, 2024, covering fiscal year 2023 operations while still pursuing a qualifying business combination. Sign up at SpacDesk for complete filing history, timeline data, and deal metrics on ARYD and the full SPAC universe.